Stage III Nasopharyngeal Carcinoma AJCC v8 Clinical Trials

6 clinical trials for Stage III Nasopharyngeal Carcinoma AJCC v8 across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) — RECRUITING · PHASE2
• Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer — RECRUITING · PHASE2
• Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer — RECRUITING · PHASE2
• Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma — RECRUITING · NA
• Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer — RECRUITING
• Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer — COMPLETED · PHASE1

Refine this search